Phase III Gazyva Trial Fails to Meet Primary Endpoint of Improving PFS in DLBCL August 04, 2016Vol.39 No.07
Free Five-Year Adcetris Results Show Patients with Long-term Control of Hodgkin Lymphoma August 04, 2016Vol.39 No.07
Trial: Erbitux-FOLFOX Therapy Improves PFS, OS in RAS Wild-Type Colorectal Cancer August 04, 2016Vol.39 No.07
Niraparib Demonstrates Prolonged PFS In Phase III Trial, Achieving Primary Endpoint August 04, 2016Vol.39 No.07
Kyprolis, Lenalidomide and Dexamethasone Combination Improves PFS, OS in Phase III July 01, 2016Vol.39 No.06
